CereVu Medical, Inc.

CereVu Medical, Inc. has developed a proprietary, AI-driven medical technology system designed for the objective, real-time measurement of pain and dyspnea. The platform utilizes a wearable sensor array—consisting of a single-use patch applied to the forehead—that communicates with a monitoring console to continuously track vital signs, including heart rate, respiratory rate, and SpO2. The core innovation lies in the use of near-infrared spectroscopy and proprietary algorithms that translate personalized cerebral hemodynamic information into continuous, objective pain indices. This technology differentiates itself by moving away from subjective pain reporting to provide clinicians with quantifiable physiological data, supported by over 90% accuracy in clinical studies.

This objective assessment capability addresses a critical gap in modern medicine, where the subjective nature of pain management often leads to inefficient treatment for the millions of Americans suffering from chronic or acute conditions. By enabling continuous, non-invasive monitoring, the CereVu system assists healthcare providers in tracking the effectiveness of pain treatments in real-time, facilitating more personalized and timely clinical interventions. The company has validated its approach through multiple clinical studies conducted with leading research institutions and has secured federal grant funding from organizations such as the National Science Foundation and the FDA. Recent implementations include monitoring in diverse settings, such as labor and delivery departments and chronic pain management clinics.